KNTE · Categories · Form 4

KNTE - SEC Form 4 insider transactions

Kinnate Biopharma Inc. (KNTE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for KNTE

• 789d
  Tananbaum James B. returned 13,718,311 shares to the company (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  Krishnamohan Neha returned 64,087 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  SEC Form 4 filed by Mitchell Dean J

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  Farzan Nima returned 2,186 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  SEC Form 4 filed by Epperly Melissa B,

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  SEC Form 4 filed by Smaldone Alsup Laurie

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  Flaherty Keith T. returned 66,377 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  SEC Form 4 filed by Sabzevari Helen

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  SEC Form 4 filed by Rome Michael E

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  Meltz Mark A returned 27,578 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  SEC Form 4 filed by Desimone Jill

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  Gordon Carl L returned 8,009,729 shares to the company (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  Orbimed Advisors Llc returned 8,009,729 shares to the company (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 789d
  Foresite Capital Management Iv, Llc returned 13,718,311 shares to the company (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 819d
  Krishnamohan Neha covered exercise/tax liability with 1,506 shares, decreasing direct ownership by 2% to 64,087 units (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 819d
  Williams Richard Thomas covered exercise/tax liability with 558 shares, decreasing direct ownership by 0.82% to 67,588 units (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 819d
  Meltz Mark A covered exercise/tax liability with 558 shares, decreasing direct ownership by 2% to 27,578 units (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 910d
  Williams Richard Thomas covered exercise/tax liability with 541 shares, decreasing direct ownership by 0.79% to 68,146 units (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 910d
  Meltz Mark A covered exercise/tax liability with 541 shares, decreasing direct ownership by 2% to 28,136 units (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 910d
  Krishnamohan Neha covered exercise/tax liability with 1,459 shares, decreasing direct ownership by 2% to 65,593 units (SEC Form 4)

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1001d
  SEC Form 4: Krishnamohan Neha covered exercise/tax liability with 1,459 shares, decreasing direct ownership by 2% to 67,052 units

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1001d
  SEC Form 4: Williams Richard Thomas covered exercise/tax liability with 541 shares, decreasing direct ownership by 0.78% to 68,687 units

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1001d
  SEC Form 4: Meltz Mark A covered exercise/tax liability with 541 shares, decreasing direct ownership by 2% to 28,677 units

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1085d
  SEC Form 4 filed by Sabzevari Helen

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1085d
  SEC Form 4 filed by Smaldone Alsup Laurie

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1085d
  SEC Form 4 filed by Mitchell Dean J

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1085d
  SEC Form 4 filed by Gordon Carl L

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1085d
  SEC Form 4 filed by Flaherty Keith T.

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1085d
  SEC Form 4 filed by Epperly Melissa B,

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1094d
  SEC Form 4 filed by Williams Richard Thomas

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1094d
  SEC Form 4 filed by Meltz Mark A

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1094d
  SEC Form 4 filed by Krishnamohan Neha

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1120d
  SEC Form 4 filed by Tananbaum James B.

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1120d
  SEC Form 4 filed by Foresite Capital Management Iv, Llc

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1122d
  SEC Form 4 filed by Orbimed Advisors Llc

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1122d
  SEC Form 4 filed by Gordon Carl L

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1127d
  SEC Form 4 filed by Gordon Carl L

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1127d
  SEC Form 4 filed by Orbimed Advisors Llc

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1196d
  SEC Form 4: Orbimed Advisors Llc was granted 1,100,000 shares

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1197d
  SEC Form 4: Gordon Carl L was granted 1,100,000 shares

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1197d
  SEC Form 4: Tananbaum James B. acquired 1,100,000 shares

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1197d
  SEC Form 4: Foresite Capital Management Iv, Llc acquired 1,100,000 shares

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1204d
  SEC Form 4 filed by Farzan Nima (Amendment)

  4/A - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1204d
  SEC Form 4 filed by Meltz Mark A

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1204d
  SEC Form 4 filed by Farzan Nima

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1204d
  SEC Form 4 filed by Williams Richard Thomas

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1204d
  SEC Form 4 filed by Krishnamohan Neha

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1278d
  SEC Form 4: Meltz Mark A covered exercise/tax liability with 541 shares, decreasing direct ownership by 2% to 27,924 units

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1278d
  SEC Form 4: Williams Richard Thomas covered exercise/tax liability with 541 shares, decreasing direct ownership by 0.79% to 67,933 units

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1278d
  SEC Form 4: Krishnamohan Neha covered exercise/tax liability with 1,459 shares, decreasing direct ownership by 2% to 69,099 units

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1370d
  SEC Form 4: Williams Richard Thomas was granted 25,000 shares, increasing direct ownership by 58% to 68,474 units

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1370d
  SEC Form 4: Meltz Mark A was granted 25,000 shares, increasing direct ownership by 722% to 28,465 units

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1370d
  SEC Form 4: Krishnamohan Neha was granted 67,500 shares, increasing direct ownership by 4,455% to 69,015 units

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1449d
  SEC Form 4 filed by Mitchell Dean J

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1449d
  SEC Form 4 filed by Flaherty Keith T.

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1449d
  SEC Form 4 filed by Sabzevari Helen

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1449d
  SEC Form 4 filed by Smaldone Alsup Laurie

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1449d
  SEC Form 4 filed by Tananbaum James B.

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1449d
  SEC Form 4 filed by Epperly Melissa B,

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)
• 1449d
  SEC Form 4 filed by Rome Michael E

  4 - Kinnate Biopharma Inc. (0001797768) (Issuer)

Other KNTE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends